Pharmaceutical product company that focuses its R&D activities on the development of new drugs

Kither Biotech is a biopharma company founded by Prof. Emilio Hirsch, Prof. Alberto Bardelli and Marco Kevin Malisani. The company aims to identify and develop new drug candidates for the treatment of pulmonary diseases, with specific focus on cystic fibrosis and idiopathic pulmonary fibrosis.

Kither Biotech is a spin-off from the University of Turin and actively collaborates with the Molecular Biotechnology Center (University of Turin) and other research centres in the world. The company developed a pipeline of treatments currently under preclinical development, with programs in cystic fibrosis, asthma, COPD, idiopathic pulmonary fibrosis and other therapeutic areas.

Date of investment July, 2019

Offices Turin, Italy

Life Science

Founding team

Marco Kevin Malisani
CEO & Co-Founder

Alessandra Ghigo